KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elanco Animal Health (ELAN) EBIT Margin (2017 - 2025)

Elanco Animal Health's EBIT Margin history spans 9 years, with the latest figure at 13.81% for Q4 2025.

  • For Q4 2025, EBIT Margin rose 6793.0% year-over-year to 13.81%; the TTM value through Dec 2025 reached 16.86%, up 5099.0%, while the annual FY2025 figure was 16.86%, 5099.0% up from the prior year.
  • EBIT Margin for Q4 2025 was 13.81% at Elanco Animal Health, down from 14.69% in the prior quarter.
  • Across five years, EBIT Margin topped out at 20.87% in Q1 2025 and bottomed at 148.31% in Q3 2023.
  • The 5-year median for EBIT Margin is 46.52% (2023), against an average of 38.28%.
  • The largest annual shift saw EBIT Margin plummeted -9802bps in 2023 before it surged 15482bps in 2024.
  • A 5-year view of EBIT Margin shows it stood at 57.1% in 2021, then grew by 5bps to 54.42% in 2022, then decreased by -14bps to 62.13% in 2023, then grew by 13bps to 54.12% in 2024, then skyrocketed by 126bps to 13.81% in 2025.
  • Per Business Quant, the three most recent readings for ELAN's EBIT Margin are 13.81% (Q4 2025), 14.69% (Q3 2025), and 17.81% (Q2 2025).